Page last updated: 2024-08-24

dexfenfluramine and Weight Reduction

dexfenfluramine has been researched along with Weight Reduction in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (30.00)18.2507
2000's6 (60.00)29.6817
2010's0 (0.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Bazarganipour, F; Jahanfar, S; Taghavi, SA; van Wely, M1
Bénardeau, A; Künnecke, B; Verry, P; von Kienlin, M1
Blanck, HM; Khan, LK; Serdula, MK1
Rissanen, A1
De Leeuw, IH; Van Gaal, LF; Wauters, MA1
Bray, GA; Glancy, DL; Greenway, F; Helmcke, F; Ryan, DH; Sander, G; Subramaniam, P; Volaufova, J1
Foreyt, JP; Poston, WS1
Alberto, G; Gamba, S; Mostert, M; Musso, A; Novi, RF; Piccinini, M; Rabbone, I; Rinaudo, MT; Vai, S1
Cavaliere, H; Halpern, A; Knobel, M; Lima, N; Medeiros-Neto, G1
Ryan, DH1

Reviews

5 review(s) available for dexfenfluramine and Weight Reduction

ArticleYear
Pharmacological and non-pharmacological strategies for obese women with subfertility.
    The Cochrane database of systematic reviews, 2021, Mar-25, Volume: 3

    Topics: Abortion, Spontaneous; Appetite Depressants; Bias; Carnitine; Clomiphene; Dexfenfluramine; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Infertility, Female; Life Style; Liraglutide; Live Birth; Mental Health; Metformin; Obesity; Pregnancy; Quality of Life; Randomized Controlled Trials as Topic; Weight Loss

2021
Pharmacological intervention: the antiobesity approach.
    European journal of clinical investigation, 1998, Volume: 28 Suppl 2

    Topics: Appetite Depressants; Blood Glucose; Controlled Clinical Trials as Topic; Cyclobutanes; Dexfenfluramine; Diabetes Mellitus, Type 2; Humans; Lactones; Longitudinal Studies; Obesity; Orlistat; Weight Loss

1998
Anti-obesity drugs: what does sibutramine offer? An analysis of its potential contribution to obesity treatment.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 1998, Volume: 106 Suppl 2

    Topics: Adipose Tissue; Appetite Depressants; Blood Glucose; Blood Pressure; Cyclobutanes; Dexfenfluramine; Dose-Response Relationship, Drug; Energy Intake; Energy Metabolism; Humans; Lipids; Obesity; Weight Loss

1998
Scientific and legal issues in fenfluramine/dexfenfluramine litigation.
    Texas medicine, 2000, Volume: 96, Issue:2

    Topics: Anti-Obesity Agents; Dexfenfluramine; Fenfluramine; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Legislation, Medical; Neurotoxicity Syndromes; Risk Assessment; Science; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Weight Loss

2000
Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity.
    Endocrine, 2000, Volume: 13, Issue:2

    Topics: Adrenergic Agents; Appetite Depressants; Cyclobutanes; Dexfenfluramine; Dextroamphetamine; Fenfluramine; Heart Valve Diseases; Humans; Obesity; Phenylpropanolamine; Serotonin Agents; Weight Loss

2000

Trials

1 trial(s) available for dexfenfluramine and Weight Reduction

ArticleYear
In obese individuals dexfenfluramine corrects molecular derangements reflecting insulin resistance.
    International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 2000, Volume: 24, Issue:6

    Topics: Adult; Blood Glucose; Body Mass Index; Dexfenfluramine; Diabetes Mellitus; Enzyme Activation; Female; Humans; Insulin; Insulin Resistance; Lymphocytes; Male; Middle Aged; Obesity; Placebos; Pyruvate Dehydrogenase Complex; Weight Loss

2000

Other Studies

4 other study(ies) available for dexfenfluramine and Weight Reduction

ArticleYear
Quantitative body composition analysis in awake mice and rats by magnetic resonance relaxometry.
    Obesity research, 2004, Volume: 12, Issue:10

    Topics: Animals; Anti-Obesity Agents; Body Composition; Calibration; Cross-Sectional Studies; Cyclobutanes; Dexfenfluramine; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred AKR; Mice, Inbred C57BL; Mice, Obese; Obesity; Rats; Rats, Sprague-Dawley; Rats, Wistar; Rats, Zucker; Reproducibility of Results; Sensitivity and Specificity; Weight Loss

2004
Prescription weight loss pill use among Americans: patterns of pill use and lessons learned from the fen-phen market withdrawal.
    Preventive medicine, 2004, Volume: 39, Issue:6

    Topics: Adult; Anti-Obesity Agents; Body Mass Index; Dexfenfluramine; Female; Fenfluramine; Humans; Life Style; Male; Middle Aged; Obesity; Product Surveillance, Postmarketing; Serotonin Agents; Socioeconomic Factors; Surveys and Questionnaires; United States; Weight Loss

2004
Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine.
    Obesity research, 1999, Volume: 7, Issue:4

    Topics: Aortic Valve Insufficiency; Appetite Depressants; Body Mass Index; Counseling; Dexfenfluramine; Drug Therapy, Combination; Echocardiography; Female; Fenfluramine; Humans; Incidence; Male; Mazindol; Middle Aged; Mitral Valve Insufficiency; Obesity; Observer Variation; Phentermine; Prevalence; Weight Loss

1999
Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat.
    International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 2000, Volume: 24, Issue:11

    Topics: Adult; Aged; Body Mass Index; Case-Control Studies; Cohort Studies; Dexfenfluramine; Diet, Reducing; Humans; Insulin; Luteinizing Hormone; Male; Middle Aged; Obesity, Morbid; Radioimmunoassay; Testis; Testosterone; Weight Loss

2000